Connect Biopharma Holdings Limited
CNTB
$2.05
-$0.10-4.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -186.88% | -18.16% | 26.41% | 26.41% | 197.44% |
| Total Depreciation and Amortization | 5.56% | 5.49% | -13.62% | -13.62% | -36.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -66.50% | -40.75% | 64.84% | 64.84% | 443.68% |
| Change in Net Operating Assets | 97.87% | -108.75% | -79.60% | -79.60% | -2,476.51% |
| Cash from Operations | -63.63% | -1,585.11% | 5.72% | 5.72% | 50.60% |
| Capital Expenditure | -4.48% | -- | -250.96% | -250.96% | -100.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 55.20% | -322.29% | -137.89% | -137.89% | -79.64% |
| Cash from Investing | 59.78% | -323.15% | -138.46% | -138.46% | -81.17% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 2.78% | 2.78% | -- |
| Issuance of Common Stock | 33.06% | -- | 443.48% | 443.48% | 1,000.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 33.06% | -- | 63.47% | 63.47% | 298.36% |
| Foreign Exchange rate Adjustments | 119.61% | 133.94% | -41.85% | -41.85% | 196.23% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -66.05% | -461.73% | -231.02% | -231.02% | -427.97% |